Table 3.

Multivariate analysis of outcomes

Outcome	Number	Hazard ratio (95% CI)	p-value
Relapse
HRM vs non-HRM	125	1.83 (1.41–2.36)	<0.0001
Pre-transplant CR	109	1	<0.0001
VGPR	208	1.2 (0.8–1.7)	0.3032
PR	343	1.7 (1.2–2.3)	0.0014
SD	34	2.0 (1.1–3.3)	0.0084
Progression	21	3.2 (1.8–5.7)	<0.0001
Planned post-transplant therapy	391	1	0.0002
None	235	1.5 (1.2–1.9)	0.0002
Missing	88	0.9 (0.6–1.3)	0.6177
Progression-free survival
HRM vs non-HRM	125	1.8 (1.4–2.4)	<0.0001
Pre-transplant CR	109	1	<0.0001
VGPR	208	1.2 (0.8–1.7)	0.3984
PR	343	1.6 (1.1–2.2)	0.0026
SD	34	1.8 (1.1–3.1)	0.0156
Progression	21	3.0 (1.7–5.3)	0.0001
Planned post-transplant therapy	391	1	<0.0001
None	235	1.6 (1.2–2.0)	<0.0001
Missing	88	0.9 (0.6–1.4)	0.6926
Overall survival
HRM vs non-HRM	125	2.24 (1.53–3.27)	<0.0001
Black vs White	131	1.7 (1.1–2.5)	0.0061
ISS/DSS III Yes vs No	221	1.8 (1.2–2.5)	0.0034
Pre-transplant CR	109	1	0.0042
VGPR	208	2.0 (1.0–3.8)	0.0244
PR	343	2.2 (1.2–4.0)	0.0054
SD	34	2.2 (0.8–5.4)	0.0996
Progression	21	5.0 (2.1–11.3)	0.0001
Planned post-transplant therapy	391	1	0.0010
None	236	1.9 (1.3–2.8)	0.0002
Missing	88	1.3 (0.7–2.4)	0.2892